Clinical trial
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men…
NCT00211094 · Alza Corporation, DE, USA, Industry · Completed
Key facts
| NCT number | NCT00211094 |
|---|---|
| Title | A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation |
| Official title | A Placebo-Controlled, Double-blind, Randomized, Parallel Study of the Efficacy and Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation |
| Lead sponsor | Alza Corporation, DE, USA, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ejaculation |
| Intervention type | Drug |
| Interventions | Dapoxetine |
| Enrollment | 1,320 |
| Completion | Jun 1, 2004 |
| First posted | Sep 21, 2005 |
| Last update posted | Feb 11, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: